======= USP3 ======= == Gene Information == * **Official Symbol**: USP3 * **Official Name**: ubiquitin specific peptidase 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9960|9960]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6I4|Q9Y6I4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=USP3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604728|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Hydrolase that deubiquitinates monoubiquitinated target proteins such as histone H2A and H2B. Required for proper progression through S phase and subsequent mitotic entry. May regulate the DNA damage response (DDR) checkpoint through deubiquitination of H2A at DNA damage sites. Associates with the chromatin. {ECO:0000269|PubMed:17980597}. |zf-UBP| |UCH| |histone deubiquitination| |Flemming body| |promoter-specific chromatin binding| |cytoplasmic ribonucleoprotein granule| |thiol-dependent ubiquitin-specific protease activity| |histone binding| |nuclear chromatin| |protein deubiquitination| |regulation of protein stability| |protein modification by small protein removal| |histone modification| |covalent chromatin modification| |RNA polymerase II proximal promoter sequence-specific DNA binding| |DNA repair| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |mitotic cell cycle| |protein catabolic process| |chromatin organization| |DNA metabolic process| |cellular response to DNA damage stimulus| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |macromolecule catabolic process| |organonitrogen compound catabolic process| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |proteolysis| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |cellular response to stress| |negative regulation of gene expression| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.94| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.94| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-1.83| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.81| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.73| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-1.72| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.01| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.423| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5127 * **Expression level (log2 read counts)**: 5.96 {{:chemogenomics:nalm6 dist.png?nolink |}}